Apixaban for Patients With Atrial Fibrillation on Hemodialysis: A Multicenter Randomized Controlled Trial

Safety and Efficacy of Vitamin K Antagonists versus Rivaroxaban in Hemodialysis Patients with Atrial Fibrillation: A Multicenter Randomized Controlled Trial

(2021) An S. De Vriese et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Oral Anticoagulation for Patients With Atrial Fibrillation on Long-Term Dialysis

(2020) Toshiki Kuno et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Apixaban Versus Warfarin in Patients With Atrial Fibrillation and Advanced Chronic Kidney Disease

(2020) John W. Stanifer et al.   CIRCULATION

Oral Anticoagulation and Cardiovascular Outcomes in Patients With Atrial Fibrillation and End-Stage Renal Disease

(2020) Sean D. Pokorney et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Apixaban: A Clinical Pharmacokinetic and Pharmacodynamic Review

(2019) Wonkyung Byon et al.   CLINICAL PHARMACOKINETICS

Outcomes Associated with Apixaban Use in End-Stage Kidney Disease Patients with Atrial Fibrillation in the United States

(2018) Konstantinos C. Siontis et al.   CIRCULATION

Apixaban Pharmacokinetics at Steady State in Hemodialysis Patients

(2017) Thomas A. Mavrakanas et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Warfarin utilisation and anticoagulation control in patients with atrial fibrillation and chronic kidney disease

(2016) Felix Yang et al.   HEART

Pharmacokinetics, pharmacodynamics, and safety of apixaban in subjects with end-stage renal disease on hemodialysis

(2015) Xiaoli Wang et al.   JOURNAL OF CLINICAL PHARMACOLOGY

Warfarin Use and the Risk for Stroke and Bleeding in Patients With Atrial Fibrillation Undergoing Dialysis

(2014) Mitesh Shah et al.   CIRCULATION

A Pint of Sweat Will Save a Gallon of Blood

(2014) Christopher B. Granger et al.   CIRCULATION

Efficacy and safety of apixaban compared with warfarin according to age for stroke prevention in atrial fibrillation: observations from the ARISTOTLE trial

(2014) S. Halvorsen et al.   EUROPEAN HEART JOURNAL

Incidence and prediction of ischemic stroke among atrial fibrillation patients with end-stage renal disease requiring dialysis

(2014) Tze-Fan Chao et al.   HEART RHYTHM

Statin Use and Calcific Uremic Arteriolopathy: A Matched Case-Control Study

(2013) Sagar U. Nigwekar et al.   AMERICAN JOURNAL OF NEPHROLOGY

Evaluation of risk stratification schemes for ischaemic stroke and bleeding in 182 678 patients with atrial fibrillation: the Swedish Atrial Fibrillation cohort study

(2012) Leif Friberg et al.   EUROPEAN HEART JOURNAL

Efficacy of apixaban when compared with warfarin in relation to renal function in patients with atrial fibrillation: insights from the ARISTOTLE trial

(2012) Stefan H. Hohnloser et al.   EUROPEAN HEART JOURNAL

Stroke and Bleeding in Atrial Fibrillation with Chronic Kidney Disease

(2012) Jonas Bjerring Olesen et al.   NEW ENGLAND JOURNAL OF MEDICINE

Apixaban versus Warfarin in Patients with Atrial Fibrillation

(2011) Christopher B. Granger et al.   NEW ENGLAND JOURNAL OF MEDICINE

Warfarin in haemodialysis patients with atrial fibrillation: what benefit?

(2010) F. Yang et al.   EUROPACE

Atrial fibrillation in hemodialysis patients: clinical features and associations with anticoagulant therapy

(2010) Volker Wizemann et al.   KIDNEY INTERNATIONAL

Warfarin Use Associates with Increased Risk for Stroke in Hemodialysis Patients with Atrial Fibrillation

(2009) K. E. Chan et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY